CVS vs Walgreens: Which Pharmacy Chain Is More Ethical? (2026)

CVS vs Walgreens: Which Pharmacy Chain Is More Ethical? (2026)

CVS and Walgreens fill roughly a third of America's prescriptions between them. They also sit at the centre of the country's two largest healthcare scandals of the past decade: the opioid epidemic and the opaque pricing machinery of pharmacy benefit managers.

So which chain is the more ethical place to spend your money, or hold in your portfolio? The honest answer is that neither is clean, and the data points to a single recurring tension. Both companies do genuine good in expanding access to care. Both have a serious record of conduct problems behind the counter and in the boardroom.

Below we compare CVS Health and Walgreens Boots Alliance across the eleven Mashinii values. Scores run from -100 to +100. A score of 0 means no verified adverse record exists, which is not the same as a clean bill of health.

The headline: health access versus business conduct

Strip away the noise and one split defines both companies.

On Better Health for All, both score positive. CVS leads at 40, Walgreens at 30. This reflects what these chains are for. They put pharmacies within reach of most of the population, run vaccination programmes at scale, and operate retail clinics that absorb demand the primary-care system cannot.

On Honest & Fair Business, both score deeply negative. CVS sits at -40, Walgreens at -30. This is the opioid record, the billing and reimbursement disputes, and at CVS the pricing conduct of its benefits arm. The same firms that widen access to medicine have repeatedly been found to cut corners on how that medicine is sold and paid for.

That contradiction is the story. It is not a rounding error or a legacy issue. It is structural to how vertically integrated pharmacy businesses make money.

Score-by-score comparison

Where CVS scores worse

CVS carries the heavier negative load, and most of it traces to scale and integration. CVS owns Caremark, one of the three pharmacy benefit managers that together control the vast majority of US prescription claims.

On Fair Money & Economic Opportunity, CVS scores -20 against Walgreens at 0. The gap is the PBM. Caremark's pricing practices have drawn sustained regulatory and legislative scrutiny over spread pricing, rebate retention, and the steering of patients toward CVS-owned pharmacies. Walgreens does not run a PBM of comparable weight, so it carries no verified adverse record on this measure.

CVS also scores worse on Honest & Fair Business at -40 to -30. The opioid distribution settlements landed on both companies, each paying into multi-billion-dollar national agreements to resolve claims that they failed to flag suspicious painkiller volumes. CVS's deeper conduct record, spanning billing and reimbursement matters alongside opioids, pulls its score lower.

On Fair Trade & Ethical Sourcing and Zero Waste & Sustainable Products, CVS scores -20 where Walgreens registers 0. Here the difference reflects what is documented rather than a clean record at Walgreens. A 0 means nothing adverse has been verified, not that the supply chain is exemplary.

Where the two chains converge

For most values, the two are close enough to be indistinguishable.

Both score -30 on Planet-Friendly Business, reflecting the environmental footprint of nationwide retail and distribution networks. Both score 25 on Respect for Cultures & Communities, a rare positive that recognises community pharmacy programmes and local health outreach. Both score -10 on Kind to Animals and 0 on No War, No Weapons.

On Fair Pay & Worker Respect, both score negative, CVS at -30 and Walgreens at -20. Pharmacy staffing has become a flashpoint. Pharmacists at both chains have staged walkouts over understaffing, arguing that workloads compromise patient safety and their own ability to catch errors. The disputes are live and ongoing.

On Safe & Smart Tech, Walgreens scores worse at -30 against CVS at -20, reflecting data-handling and digital-health concerns across health platforms that touch sensitive patient information.

What this means for shoppers and investors

There is no version of this comparison where one chain is clearly ethical and the other is not. CVS is the larger, more integrated business, and that integration is exactly what generates its worse scores on money and conduct. Walgreens is narrower, which leaves it with fewer verified adverse records but no real claim to leadership.

If your priority is health access, both deliver, with CVS marginally ahead. If your concern is corporate conduct and pricing fairness, Walgreens is the modestly less compromised of the two, and the absence of a Caremark-style PBM is the main reason.

Store closures complicate the access picture further. Both chains have shut hundreds of locations, and the cuts fall hardest on lower-income and rural areas, eroding the access advantage that earns them their only strong positive scores.

The deeper lesson sits across the sector. Pharmacy chains are not uniquely bad actors so much as a clear case study in how scale and vertical integration in healthcare reward conduct that regulators later have to unwind. For the wider pattern, see our analysis of patient access and fair pricing in big pharma and our ranking of the most ethical healthcare companies of 2026.

See where your money sits

Want to know whether you already own CVS, Walgreens, or their peers through a fund? Run a free check.

Audit your portfolio to see your exposure across all eleven values, or search any company to pull its full ethics breakdown before you buy.